Targeted delivery of siRNA.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

26 citing papers in PubMed.

1. Nanotechnology in Ovarian Cancer: Advances in Early Diagnosis and Targeted Therapy to Enhance Patient Quality of Life.Cells · 2026
   Review
2. Small interfering RNA: From designing to therapeutic in cancer.Journal, genetic engineering & biotechnology · 2025
   Review
3. Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro.Molecular biology reports · 2023
   Article
4. siRNA-Mediated MELK Knockdown Induces Accelerated Wound Healing with Increased Collagen Deposition.International journal of molecular sciences · 2023
   Article
5. Modulating the Blood-Brain Barrier: A Comprehensive Review.Pharmaceutics · 2021
   Review
6. A putative role for lncRNAs in epigenetic regulation of memory.Neurochemistry international · 2021
   Review
7. Modulating Polymer-siRNA Binding Does Not Promote Polyplex-Mediated Silencing.Nucleic acid therapeutics · 2021
   Article
8. A Unique Gene-Silencing Approach, Using an Intelligent RNA Expression Device (iRed), Results in Minimal Immune Stimulation When Given by Local Intrapleural Injection in Malignant Pleural Mesothelioma.Molecules (Basel, Switzerland) · 2020
   Article
9. RNAi therapeutic strategies for acute respiratory distress syndrome.Translational research : the journal of laboratory and clinical medicine · 2019
   Review
10. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.Advanced materials (Deerfield Beach, Fla.) · 2019
    Review
11. The current state and future directions of RNAi-based therapeutics.Nature reviews. Drug discovery · 2019
    Review
12. Frontal Bone Healing Is Sensitive to Wnt Signaling Inhibition via Lentiviral-Encoded Beta-Catenin Short Hairpin RNA.Tissue engineering. Part A · 2018
    Article
13. Effective carrier-free gene-silencing activity of cholesterol-modified siRNAs.RSC advances · 2018
    Article
14. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.Nucleic acid therapeutics · 2018
    Review
15. RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.International journal of nanomedicine · 2018
    Review
16. Nucleases as a barrier to gene silencing in the cotton boll weevil, Anthonomus grandis.PloS one · 2017
    Article
17. Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.PloS one · 2017
    Article
18. Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2016
    Review
19. Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide.International journal of nanomedicine · 2015
    Article
20. Tumor-targeted RNA-interference: functional non-viral nanovectors.American journal of cancer research · 2011
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract